Correlation of Disease Severity with Fecal Toxin Levels in Patients with Clostridium difficile -Associated Diarrhea and Distribution of PCR Ribotypes and Toxin Yields In Vitro of Corresponding Isolates
Open Access
- 1 February 2006
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (2), 353-358
- https://doi.org/10.1128/jcm.44.2.353-358.2006
Abstract
We investigated in vivo and in vitro yields of toxins A and B from and PCR ribotypes of Clostridium difficile isolates from 164 patients with differing severities of C. difficile-associated diarrhea (CDAD) (patients were grouped as follows: 10 per day, n = 22). The median fecal toxin levels in each group were 0.5, 6.8, and 149 U/g feces (P < 0.001), respectively. Patients with severe diarrhea also had more-frequent occurrence of blood in stool and vomiting, but there was no association with fecal toxin levels per se. There was no correlation between fecal toxin level and toxin yield in vitro for the corresponding C. difficile isolate or between its PCR ribotype and disease severity. A broad range of toxin yields among isolates belonging to major PCR ribotypes indicated a presence of many subtypes. We hypothesize that bacterial and host factors that affect C. difficile toxin levels in feces are important determinants of symptoms in CDAD patients. An inverse correlation between toxin yield and spore count (r = 0.66) in stationary-phase cultures supported the notion that toxin production and sporulation represent opposite alternative survival strategies for C. difficile cells facing nutrient shortage.Keywords
This publication has 50 references indexed in Scilit:
- Effect of Antibiotic Treatment on Growth of and Toxin Production by Clostridium difficile in the Cecal Contents of MiceAntimicrobial Agents and Chemotherapy, 2005
- Molecular Epidemiology of EndemicClostridium difficileInfection and the Significance of Subtypes of the United Kingdom Epidemic Strain (PCR Ribotype 1)Journal of Clinical Microbiology, 2005
- Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severityCMAJ : Canadian Medical Association Journal, 2004
- Epidemiology and Molecular Characterization of Clostridium difficile Strains from Patients with Diarrhea: Low Disease Incidence and Evidence of Limited Cross-Infection in a Swedish Teaching HospitalJournal of Clinical Microbiology, 2003
- Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gutJournal of Antimicrobial Chemotherapy, 2003
- Clostridium difficile Genotyping Based on slpA Variable Region in S-Layer Gene Sequence: an Alternative to SerotypingJournal of Clinical Microbiology, 2002
- Toxins, Butyric Acid, and Other Short-Chain Fatty Acids Are Coordinately Expressed and Down-Regulated by Cysteine in Clostridium difficileInfection and Immunity, 2000
- Suppression of toxin production in Clostridium difficile VPI 10463 by amino acidsMicrobiology, 1999
- Effect of Fiber Source on Short-Chain Fatty Acid Production and on the Growth and Toxin Production by Clostridium difficileScandinavian Journal of Gastroenterology, 1994
- The significance of quantitative results of C. Difficile cultures and toxin assays in patients with diarrheaDiseases of the Colon & Rectum, 1985